Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation is a research paper published in Translational Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Natural Science Foundation of China
Grant: 81972836
American Cancer Society
Grant: 132574-CSDG-18-139-01-CSM
Science and Technology Program of Hunan Province
Grant: 2020SK2120
National Cancer Institute
Grant: P01 CA111412
National Cancer Institute
Grant: R35 CA197292
NIGMS NIH HHS
Grant: K12 GM119955
National Institutes of Health
Grant: 5P01CA111412-04
NK Cells, Their Receptors and Unrelated Donor Transplant
National Institutes of Health
Grant: 5R35CA197292-02
Viral priming and targeting NK cells against solid tumor malignancies
Randy Shaver Cancer Research and Community Fund
Minnesota Ovarian Cancer Alliance
NIH
University of Minnesota
FWCI
1.39
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals